Benefits and risks of pharmacological moking cessation therapies in chronic obstructive pulmonary disease

E Wagena, Maurice Zeegers, C Van Schayck, E Wouters

    Research output: Contribution to journalArticle

    Original languageEnglish
    Pages (from-to)381-403
    Number of pages23
    JournalDrug Safety
    Volume2003
    Issue number26
    Publication statusPublished - 1 Jan 2003

    Cite this